Deal title

Principal company

Partner company

Total paid (US$M)

Technologies

Date

June

Johnson & Johnson acquires Actelion

Actelion Ltd.

Johnson & Johnson

$30,000

Small-molecule therapeutic (primary); Film coating; Oral formulation; Tablet formulation

6/16/17

UCB Pharma acquires Beryllium Discovery

Beryllium Discovery Corp.

UCB Pharma Ltd.

Unknown

Other technologies (primary); Service laboratory deal

6/6/17

Cell Medica acquires Catapult Therapy TCR

Catapult Therapy TCR Ltd.

Cell Medica Ltd.

Unknown

Cell therapy (primary)

6/20/17

Intrexon acquires Genvec

Genvec Inc.

Intrexon Corp.

Unknown

N/A

6/16/17

Spherix acquires a controlling interest in Hoth Therapeutics

Hoth Therapeutics Inc.

Spherix Inc.

Unknown

Small-molecule therapeutic (primary)

6/30/17

Eco Petroleum acquires Immunotech Laboratories

Immunotech Laboratories Inc.

Eco Petroleum Solutions

Payment unspecified

Protein technology
(primary)

6/14/17

Corazon Gold acquires Nanosphere Health

Nanosphere Health Sciences LLC

Corazon Gold Corp.

$20

Nanoparticle formulation (primary)

6/20/17

Bioverativ acquires True North Therapeutics

True North Therapeutics

Bioverativ Inc.

$400

Monoclonal antibody (primary); Biological therapeutic; Immunoglobulin-G; Intravenous formulation; Monoclonal antibody humanized

6/28/17

July

Dare Bioscience reverse merges with Cerulean Pharma

Cerulean Pharma

Dare Bioscience Operations Inc.

Unknown

Small-molecule therapeutic (primary)

7/19/17

Lentigen Technology acquires UMB's Living Pharma

Living Pharma Inc.

Opus Bio Inc.

Unknown

Cell therapy (primary); T-lymphocyte

7/20/17

Norgine acquires Merus Labs

Merus Labs International Inc.

Norgine BV

Payment unspecified

Other technologies
(primary)

7/17/17

Alpine merges with Nivalis Therapeutics in an all-stock transaction

Nivalis Therapeutics

Alpine Immune Sciences Inc.

Unknown

Small-molecule therapeutic (primary)

7/24/17

August

Carlyle Group acquires Albany Molecular Research Inc.

Albany Molecular Research Inc.

The Carlyle Group

Payment unspecified

Other technologies (primary); Service laboratory deal

8/31/17

Arrow Pharmaceuticals acquires Amneal Pharmaceuticals

Amneal Pharmaceutical LLC

Arrow Pharmaceuticals Ltd.

$13.5

Generic product (primary); OTC product

8/31/17

Evotec acquires Aptuit

Aptuit

Evotec AG

$300

Other technologies
(primary)

8/16/17

Charles River Laboratories acquires Brains On-Line

Brains On-Line Holding BV

Charles River Laboratories International Inc.

$21.23

Other technologies (primary); Service laboratory deal

8/7/17

Tissue Regenix acquires Cellright Technologies

Cellright Technologies

Tissue Regenix Group plc

$25.9

Other technologies
(primary)

8/9/17

Aclaris Therapeutics acquires Confluence Life Sciences

Confluence Life Sciences Inc.

Aclaris Therapeutics Inc.

$19.69

Small-molecule therapeutic (primary); Oral formulation

8/3/17

Horizon Discovery acquires GE Healthcare Dharmacon

Dharmacon Inc.

Horizon Discovery Group plc

Unknown

Genomics (primary); Lab reagents and supplies deal

8/31/17

Mirna Therapeutics reverse merges with Synlogic

Mirna Therapeutics Inc.

Synlogic Inc.

Unknown

Small-molecule therapeutic (primary)

8/28/17

Oncogenex Pharmaceuticals reverse merges with Achieve Life Science

Oncogenex Pharmaceuticals

Achieve Life Science Inc.

Unknown

Oligonucleotide (primary)

8/1/17

Thermo Fisher Scientific acquires Patheon

Patheon Inc.

Thermo Fisher Scientific Inc.

$7,200

Other technologies (primary); Service laboratory deal

8/29/17

Molecular Templates reverse merges with Threshold Pharmaceuticals to form a combined company

Threshold Pharmaceuticals Inc.

Molecular Templates Inc.

Unknown

Small-molecule therapeutic (primary)

8/1/17

Immunoprecise acquires U-Protein

U-Protein Express BV

Immunoprecise Antibodies Ltd.

Unknown

Antibody (primary); Protein recombinant

8/23/17

Parcom Capital acquires Viroclinics Biosciences

Viroclinics Biosciences

Parcom Capital Management BV

Unknown

Other technologies
(primary)

8/29/17

CGI acquires Vivopharm

Vivopharm Pty. Ltd.

Cancer Genetics Inc.

$12

Other technologies
(primary)

8/14/17

September

GT Biopharma acquires Georgetown Translational Pharmaceuticals

Georgetown Translational Pharmaceuticals Inc.

GT Biopharma Inc.

Unknown

Small-molecule therapeutic (primary)

9/1/17

BMS acquires IFM Therapeutics

IFM Therapeutics Inc.

Bristol-Myers Squibb Co.

$300

Small-molecule therapeutic (primary)

9/7/17

Mallinckrodt acquires Infacare

Infacare Pharmaceutical Corp.

Mallinckrodt plc

$425

Small-molecule therapeutic (primary)

9/25/17

Metabolon acquires Metabolomic Discoveries

Metabolomic Discoveries GmbH

Metabolon Inc.

Unknown

Other technologies
(primary)

9/5/17

Northeast Pharmaceutical Group acquires Nanjing Real

Nanjing Real Pharmaceutical Co. Ltd.

Northeast Pharmaceutical Group Co. Ltd.

$18.29

Small-molecule therapeutic (primary)

9/4/17

Acer Therapeutics reverse merges with Opexa Therapeutics

Opexa Therapeutics

Acer Therapeutics Inc.

Unknown

Cell therapy (primary)

9/20/17

 

Notes

Source: Cortellis Deals Intelligence

No Comments